Nippon Kayaku Co (4272) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
19 Aug, 2025Executive summary
Net sales increased 2.1% year-over-year to ¥54.8 billion for FY 2025 1Q, while operating income declined between 13.3% and 21.6% to as low as ¥4.4 billion, mainly due to underperformance in Mobility & Imaging and higher raw material costs.
Profit attributable to owners rose 20.3% year-over-year to ¥4.3 billion, driven by a gain on sales of investment securities.
Ordinary income dropped 44.1% year-over-year to ¥4.1 billion, impacted by foreign exchange losses.
FY 2025 forecasts remain unchanged from initial guidance.
Financial highlights
Net sales: ¥54.8 billion (up ¥1.1 billion YoY); operating income: as low as ¥4.4 billion (down up to ¥1.0 billion YoY); ordinary income: ¥4.1 billion (down ¥3.2 billion YoY); profit: ¥4.3 billion (up ¥0.7 billion YoY).
Non-operating income swung from +¥1.7 billion to -¥0.3 billion due to foreign exchange losses.
Extraordinary income improved from -¥1.6 billion to +¥1.9 billion, mainly from gains on investment security sales.
EPS (basic and diluted) increased to ¥27.29 from ¥21.52 year-over-year.
Comprehensive income fell to ¥5,111 million from ¥9,374 million year-over-year.
Outlook and guidance
Full-year net sales forecast at ¥234.6 billion, up 5.4% year-over-year; operating income forecast at ¥20.0 billion, down 2.0% year-over-year.
Full-year profit attributable to owners forecast at ¥17.4 billion, down 0.6% year-over-year.
1H net sales progress at 49% and operating income at 46%; 2Q expects continued growth in Safety Systems in China and recovery in catalysts in Fine Chemicals.
No changes to previously announced business forecasts.
Latest events from Nippon Kayaku Co
- Profit attributable to owners of parent rose 30.1% on 4.0% sales growth, outlook steady.4272
Q3 20262 Feb 2026 - Net sales up 4.1% and profit nearly doubled on investment gains despite cost pressures.4272
Q2 202612 Nov 2025 - Strong sales and profit growth driven by Mobility & Imaging and Fine Chemicals; outlook revised up.4272
Q1 202519 Aug 2025 - Sharp profit growth and raised forecasts driven by Mobility & Imaging and Fine Chemicals.4272
Q3 202519 Aug 2025 - Sales and operating income surged, with upward guidance and major treasury stock buybacks.4272
Q2 202519 Aug 2025 - Record profit and strong segment growth; FY 2026 sees sales up, profit slightly down.4272
Q4 202519 Aug 2025